.Attribute Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view asks for incorporation of people along with MASLD and also dimension of liver end results in cardio-- renal-- metabolic tests, when information recommend mechanistically possible advantages as well as clinical safety-- and details factors to consider for trial layout and regulatory approval.